Dependency on infarct size limits the clinical applicability of non-invasive reperfusion assessment by biochemical markers in acute myocardial infarction

HeartDrug

Volumn 1, Issue 4, 2001, Pages 197-206

  Haastrup, Benedikte ^a,b   Gill, Sabine ^a   Haghfelt, Torben ^a   Hørder, Mogens ^a   Kristensen, Søren Risom ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Biochemical markers; Electrocardiography; Enzymes; Infarct size; Myocardial infarction; Reperfusion

Indexed keywords

ALTEPLASE; BIOCHEMICAL MARKER; CREATINE KINASE MB; FIBRINOLYTIC AGENT; LACTATE DEHYDROGENASE ISOENZYME; MYOGLOBIN; PLASMINOGEN ACTIVATOR; STREPTOKINASE; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; ELECTROCARDIOGRAPHY MONITORING; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 0034755588     PISSN: 14229528     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048961     Document Type: Article

References (26)

1. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
2. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
3. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: Influence of early infarct related artery patency. The GUSTO Enzyme Substudy
4. Survival 12 years after randomization to streptokinase: The influence of thrombolysis in myocardial flow at three and four weeks
5. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction
6. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis
7. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction
8. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy
9. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute rate predicts infarct related patency after thrombolysis for acute myocardial infarction: Results from the Thrombolysis in Myocardial Infarction Study (TIMI) 10B
10. Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: Use of the ST segment as a non-invasive marker
11. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction
12. Quantitative analysis of plasma enzyme levels based upon simultaneous determination of different enzymes
13. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables
14. Are enzymatic tests good indicators of coronary reperfusion?
15. One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial
16. Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction
17. Effect of reperfusion on electrocardiographic and enzymatic infarct size: Results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction
18. Prediction of myocardial infarct size from early serum myoglobin observations
19. Enzymatic estimation of the extent of irreversible myocardial injury early after reperfusion
20. Serum myoglobin for the early non-invasive detection of coronary reperfusion in patients with acute myocardial infarction
21. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction
22. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
23. Angiographic validation of bedside markers of reperfusion
24. Meta-analysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction